A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM‐STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma. The gene discussed is TGFB1; the disease is intrahepatic cholangiocarcinoma.